• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Cefotetan Disodium Injection

 Status: Currently in Shortage

 » Date first posted: 08/14/2014
 » Therapeutic Categories: Anti-Infective

B. Braun Medical Inc. (Revised 06/18/2015)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 gram/50 mL in DUPLEX (NDC 00264-3173-11) Due to demand increase, product is on allocation to contracted customers based on historical use. Increased demand for the product.
2 gram/50 mL in DUPLEX (NDC 00264-3175-11) Due to demand increase, product is on allocation to contracted customers based on historical use. Increased demand for the product.

Fresenius Kabi USA, LLC (Reverified 05/24/2016)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g SDV (NDC 63323-0385-10) Available Check wholesalers for inventory Manufacturing delay
2 g SDV (NDC 63323-0386-20) Available Check wholesalers for inventory Manufacturing delay
10 g PBP (NDC 63323-0396-61) Backordered. Next release anticipated Q3 - 2016. Manufacturing delay

Teligent (Revised 03/24/2016)

Company Contact Information:
856-697-1441

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 g SDV (NDC 52565-053-10) Product will be launched at the end of March 2016. Other
1 g SDV (NDC 52565-052-10) Product will be launched at the end of March 2016. Other
-
-